nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—BCHE—diaphragm—muscle cancer	0.597	0.597	CbGeAlD
Pralidoxime—ACHE—tendon—muscle cancer	0.0839	0.0839	CbGeAlD
Pralidoxime—ACHE—testis—muscle cancer	0.0695	0.0695	CbGeAlD
Pralidoxime—BCHE—smooth muscle tissue—muscle cancer	0.0549	0.0549	CbGeAlD
Pralidoxime—BCHE—cardiac atrium—muscle cancer	0.0473	0.0473	CbGeAlD
Pralidoxime—BCHE—bone marrow—muscle cancer	0.0399	0.0399	CbGeAlD
Pralidoxime—BCHE—vagina—muscle cancer	0.0383	0.0383	CbGeAlD
Pralidoxime—BCHE—head—muscle cancer	0.0353	0.0353	CbGeAlD
Pralidoxime—BCHE—testis—muscle cancer	0.0341	0.0341	CbGeAlD
